{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:06:42Z","timestamp":1761962802820},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Medical Science and Technology Project of Zhejiang Province","award":["2015KYB346","2017KY589"],"award-info":[{"award-number":["2015KYB346","2017KY589"]}]},{"name":"Fumin and Huimin Project of Science and Technology of Ningbo","award":["2015C50013"],"award-info":[{"award-number":["2015C50013"]}]},{"name":"Hua Mei Research Fund of Ningbo No. 2 Hospital","award":["2015HMKY10"],"award-info":[{"award-number":["2015HMKY10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00296-017-3669-6","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T07:10:07Z","timestamp":1488179407000},"page":"571-578","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigation into the association between P2RX7 gene polymorphisms and susceptibility to primary gout and hyperuricemia in a Chinese Han male population"],"prefix":"10.1007","volume":"37","author":[{"given":"Ying","family":"Ying","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"3669_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.maturitas.2014.05.001","volume":"78","author":"PC Robinson","year":"2014","unstructured":"Robinson PC, Horsburgh S (2014) Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas 78:245\u2013251","journal-title":"Maturitas"},{"key":"3669_CR2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","volume":"17","author":"TR Merriman","year":"2015","unstructured":"Merriman TR (2015) An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther 17:98","journal-title":"Arthritis Res Ther"},{"key":"3669_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncprheum0556","volume":"3","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M (2007) The changing epidemiology of gout. Nat Clin Pract Rheumatol 3:443\u2013449","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3669_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.berh.2010.10.004","volume":"24","author":"EU Smith","year":"2010","unstructured":"Smith EU, Diaz-Torne C, Perez-Ruiz F et al (2010) Epidemiology of gout: an update. Best Pract Res Clin Rheumatol 24:811\u2013827","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3669_CR5","first-page":"1155","volume":"10","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D et al (2015) Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. BilMed Res Int 10:1155","journal-title":"BilMed Res Int"},{"key":"3669_CR6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semarthrit.2013.04.007","volume":"43","author":"JH Tao","year":"2013","unstructured":"Tao JH, Zhang Y, Li XP (2013) P2 \u00d7 7R: a potential key regulator of acute gouty arthritis. Semin Arthritis Rheum 43:376\u2013380","journal-title":"Semin Arthritis Rheum"},{"key":"3669_CR7","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1096\/fj.11-1201ufm","volume":"25","author":"SE Malawista","year":"2011","unstructured":"Malawista SE, de Boisfleury AC, Naccache PH (2011) Inflammatory gout: observations over a half-century. FASEB J 25:4073\u20134078","journal-title":"FASEB J"},{"key":"3669_CR8","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","volume":"176","author":"D Ferrari","year":"2006","unstructured":"Ferrari D, Pizzirani C, Adinolfi E et al (2006) The P2 \u00d7 7 receptor: a key player in IL-1 processing and release. J Immunol 176:3877\u20133883","journal-title":"J Immunol"},{"key":"3669_CR9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/BOR.0b013e32833645e8","volume":"22","author":"HK Choi","year":"2010","unstructured":"Choi HK, Zhu Y, Mount DB (2010) Genetics of gout. Curr Opin Rheumatol 22:144\u2013151","journal-title":"Curr Opin Rheumatol"},{"key":"3669_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A Kottgen","year":"2013","unstructured":"Kottgen A, Albrecht E, Teumer A et al (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45:145\u2013154","journal-title":"Nat Genet"},{"key":"3669_CR11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877","volume":"75","author":"AJ Phipps-Green","year":"2016","unstructured":"Phipps-Green AJ, Merriman ME, Topless R (2016) Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann Rheum Dis 75:124\u2013130","journal-title":"Ann Rheum Dis"},{"key":"3669_CR12","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1096\/fj.09-150862","volume":"24","author":"L Stokes","year":"2010","unstructured":"Stokes L, Fuller SJ, Sluyter R et al (2010) Two haplotypes of the P2 \u00d7 (7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of function effect and enhanced interleukin-1 beta secretion. FASEB J 24:2916\u20132927","journal-title":"FASEB J"},{"key":"3669_CR13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.175.1.82","volume":"175","author":"G Cabrini","year":"2005","unstructured":"Cabrini G, Falzoni S, Forchap SL et al (2005) A His-155 to Tyr polymorphism confers gain-of-function to the human P2 \u00d7 7 receptor of human leukemic lymphocytes. J Immunol 175:82\u201389","journal-title":"J Immunol"},{"key":"3669_CR14","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M010353200","volume":"276","author":"BJ Gu","year":"2001","unstructured":"Gu BJ, Zhang W, Worthington RA et al (2001) A Glu-496 to Ala polymorphism leads to loss of function of the human P2 \u00d7 7 receptor. J Biol Chem 276:11135\u201311142","journal-title":"J Biol Chem"},{"key":"3669_CR15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2172-13-64","volume":"13","author":"A Wesselius","year":"2012","unstructured":"Wesselius A, Bours MJ, Arts IC et al (2012) The P2 \u00d7 (7) loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levels. BMC Immunol 13:64","journal-title":"BMC Immunol"},{"key":"3669_CR16","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/jbc.M507816200","volume":"281","author":"AN Shemon","year":"2006","unstructured":"Shemon AN, Sluyter R, Fernando SL et al (2006) A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2 \u00d7 7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 281:2079\u20132086","journal-title":"J Biol Chem"},{"key":"3669_CR17","doi-asserted-by":"crossref","first-page":"31287","DOI":"10.1074\/jbc.M313902200","volume":"279","author":"BJ Gu","year":"2004","unstructured":"Gu BJ, Sluyter R, Skarratt KK et al (2004) An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2 \u00d7 7 receptor. J Biol Chem 279:31287\u201331295","journal-title":"J Biol Chem"},{"key":"3669_CR18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301\u20131311","journal-title":"Ann Rheum Dis"},{"issue":"5262","key":"3669_CR19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","volume":"272","author":"A Surprenant","year":"1996","unstructured":"Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2 \u00d7 7). Science 272(5262):735\u2013738","journal-title":"Science"},{"key":"3669_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"RA North","year":"2002","unstructured":"North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013\u20131067","journal-title":"Physiol Rev"},{"key":"3669_CR21","first-page":"347","volume":"5","author":"GN Buell","year":"1998","unstructured":"Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA, Antonarakis SE (1998) Gene structure and chromaosomal localization of the human P2 \u00d7 7 receptor. Receptors Channels 5:347\u2013354","journal-title":"Receptors Channels"},{"issue":"3","key":"3669_CR22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood.V97.3.587","volume":"97","author":"F Di Virgilio","year":"2001","unstructured":"Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97(3):587\u2013600","journal-title":"Blood"},{"issue":"2","key":"3669_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1469-7793.1999.0335m.x","volume":"519","author":"C Virginio","year":"1999","unstructured":"Virginio C, MacKenzie A, North RA, Surprenant A (1999) Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2 \u00d7 7 receptor. J Physiol 519(Pt 2):335\u2013346","journal-title":"J Physiol"},{"issue":"2","key":"3669_CR24","first-page":"141","volume":"17","author":"T Eleftheriadis","year":"2013","unstructured":"Eleftheriadis T, Pissas G, Karioti A, Antoniadi G, Golfinopoulos S, Liakopoulos V, Mamara A, Speletas M, Koukoulis G, Stefanidis I (2013) Uric acid induces caspase-1 activation, IL-1beta secretion and P2 \u00d7 7 receptor dependent proliferation in primary human lymphocytes. Hippokratia 17(2):141\u2013145","journal-title":"Hippokratia"},{"issue":"9","key":"3669_CR25","doi-asserted-by":"publisher","first-page":"10953","DOI":"10.3390\/molecules180910953","volume":"18","author":"LA Alves","year":"2013","unstructured":"Alves LA, Bezerra RJ, Faria RX, Ferreira LG, da Silva Frutuoso V (2013) Physiological roles and potential therapeutic applications of the P2 \u00d7 7 receptor in inflammation and pain. Molecules 18(9):10953\u201310972. doi: 10.3390\/molecules180910953","journal-title":"Molecules"},{"issue":"4","key":"3669_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11302-012-9320-9","volume":"8","author":"S Gadeock","year":"2012","unstructured":"Gadeock S, Pupovac A, Sluyter V, Spildrejorde M, Sluyter R (2012) P2 \u00d7 7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells. Purinergic Signal 8(4):669\u2013676. doi: 10.1007\/s11302-012-9320-9","journal-title":"Purinergic Signal"},{"issue":"1","key":"3669_CR27","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/ar4159","volume":"15","author":"RA Terkeltaub","year":"2013","unstructured":"Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, Weinstein SP (2013) Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis Res Ther 15(1):R25. doi: 10.1186\/ar4159","journal-title":"Arthritis Res Ther"},{"key":"3669_CR28","doi-asserted-by":"publisher","unstructured":"Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis 71 (11):1839\u20131848. doi: 10.1136\/annrheumdis-2011-200908","DOI":"10.1136\/annrheumdis-2011-200908"},{"issue":"5","key":"3669_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1744-313X.2011.01019.x","volume":"38","author":"A Al-Shukaili","year":"2011","unstructured":"Al-Shukaili A, Al-Kaabi J, Hassan B, Al-Araimi T, Al-Tobi M, Al-Kindi M, Al-Maniri A, Al-Gheilani A, Al-Ansari A (2011) P2 \u00d7 7 receptor gene polymorphism analysis in rheumatoid arthritis. Int J Immunogenet 38(5):389\u2013396. doi: 10.1111\/j.1744-313X.2011.01019.x","journal-title":"Int J Immunogenet"},{"issue":"5","key":"3669_CR30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ceca.2011.08.002","volume":"50","author":"O Oyanguren-Desez","year":"2011","unstructured":"Oyanguren-Desez O, Rodriguez-Antiguedad A, Villoslada P, Domercq M, Alberdi E, Matute C (2011) Gain-of-function of P2 \u00d7 7 receptor gene variants in multiple sclerosis. Cell Calcium 50(5):468\u2013472. doi: 10.1016\/j.ceca.2011.08.002","journal-title":"Cell Calcium"},{"issue":"9349","key":"3669_CR31","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0140-6736(02)11917-9","volume":"360","author":"U Thunberg","year":"2002","unstructured":"Thunberg U, Tobin G, Johnson A, Soderberg O, Padyukov L, Hultdin M, Klareskog L, Enblad G, Sundstrom C, Roos G, Rosenquist R (2002) Polymorphism in the P2 \u00d7 7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 360(9349):1935\u20131939","journal-title":"Lancet"},{"issue":"7145","key":"3669_CR32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","unstructured":"Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661\u2013678","journal-title":"Nature"},{"issue":"1","key":"3669_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/380913","volume":"74","author":"SK Nath","year":"2004","unstructured":"Nath SK, Quintero-Del-Rio AI, Kilpatrick J, Feo L, Ballesteros M, Harley JB (2004) Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families. Am J Hum Genet 74(1):73\u201382","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3669_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11302-009-9168-9","volume":"6","author":"C Sun","year":"2010","unstructured":"Sun C, Chu J, Singh S, Salter RD (2010) Identification and characterization of a novel variant of the human P2 \u00d7 (7) receptor resulting in gain of function. Purinergic Signal 6(1):31\u201345. doi: 10.1007\/s11302-009-9168-9","journal-title":"Purinergic Signal"},{"issue":"4","key":"3669_CR35","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/jbc.M507816200","volume":"281","author":"AN Shemon","year":"2006","unstructured":"Shemon AN, Sluyter R, Fernando SL, Clarke AL, Dao-Ung LP, Skarratt KK, Saunders BM, Tan KS, Gu BJ, Fuller SJ, Britton WJ, Petrou S, Wiley JS (2006) A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2 \u00d7 7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 281(4):2079\u20132086","journal-title":"J Biol Chem"},{"issue":"3","key":"3669_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/mutage\/get007","volume":"28","author":"GM Chen","year":"2013","unstructured":"Chen GM, Feng CC, Ye QL, Tao JH, Li R, Peng H, Zhou M, Leng RX, Li J, Cen H, Fan YG, Pan HF, Ye DQ (2013) Association of P2 \u00d7 7R gene polymorphisms with systemic lupus erythematosus in a Chinese population. Mutagenesis 28(3):351\u2013355. doi: 10.1093\/mutage\/get007","journal-title":"Mutagenesis"},{"issue":"1","key":"3669_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.175.1.82","volume":"175","author":"G Cabrini","year":"2005","unstructured":"Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P, Cuneo A, Castoldi G, Baricordi OR, Di Virgilio F (2005) A His-155 to Tyr polymorphism confers gain-of-function to the human P2 \u00d7 7 receptor of human leukemic lymphocytes. J Immunol 175(1):82\u201389","journal-title":"J Immunol"},{"issue":"1\u20132","key":"3669_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cellimm.2012.05.005","volume":"276","author":"L Portales-Cervantes","year":"2012","unstructured":"Portales-Cervantes L, Nino-Moreno P, Salgado-Bustamante M, Garcia-Hernandez MH, Baranda-Candido L, Reynaga-Hernandez E, Barajas-Lopez C, Gonzalez-Amaro R, Portales-Perez DP (2012) The His155Tyr (489C > T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2 \u00d7 7 receptor in immune cells from patients with rheumatoid arthritis. Cell Immunol 276(1\u20132):168\u2013175. doi: 10.1016\/j.cellimm.2012.05.005","journal-title":"Cell Immunol"},{"issue":"6","key":"3669_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpsychires.2009.10.005","volume":"44","author":"S Roger","year":"2010","unstructured":"Roger S, Mei ZZ, Baldwin JM, Dong L, Bradley H, Baldwin SA, Surprenant A, Jiang LH (2010) Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2 \u00d7 7 receptor functions. J Psychiatr Res 44(6):347\u2013355. doi: 10.1016\/j.jpsychires.2009.10.005","journal-title":"J Psychiatr Res"},{"issue":"8","key":"3669_CR40","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1096\/fj.09-150862","volume":"24","author":"L Stokes","year":"2010","unstructured":"Stokes L, Fuller SJ, Sluyter R, Skarratt KK, Gu BJ, Wiley JS (2010) Two haplotypes of the P2 \u00d7 (7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J 24(8):2916\u20132927. doi: 10.1096\/fj.09-150862","journal-title":"FASEB J"},{"issue":"30","key":"3669_CR41","doi-asserted-by":"crossref","first-page":"31287","DOI":"10.1074\/jbc.M313902200","volume":"279","author":"BJ Gu","year":"2004","unstructured":"Gu BJ, Sluyter R, Skarratt KK, Shemon AN, Dao-Ung LP, Fuller SJ, Barden JA, Clarke AL, Petrou S, Wiley JS (2004) An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2 \u00d7 7 receptor. J Biol Chem 279(30):31287\u201331295","journal-title":"J Biol Chem"},{"issue":"14","key":"3669_CR42","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M010353200","volume":"276","author":"BJ Gu","year":"2001","unstructured":"Gu BJ, Zhang W, Worthington RA, Sluyter R, Dao-Ung P, Petrou S, Barden JA, Wiley JS (2001) A Glu-496 to Ala polymorphism leads to loss of function of the human P2 \u00d7 7 receptor. J Biol Chem 276(14):11135\u201311142","journal-title":"J Biol Chem"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3669-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T03:48:03Z","timestamp":1568864883000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3669-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3669"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3669-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}